SCHEMBL6686456

SCHEMBL6686456

CC(C)(C)CCn1c(=O)c(C2=NS(=O)(=O)c3cc(O)ccc3N2)c(O)c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.61
MAPK1 P28482 1/20 0.61
CYP2C9 P11712 3/20 0.53
NR1I2 O75469 1/20 0.53
KDM4E B2RXH2 11/20 0.40
GAA P10253 4/20 0.40
ALDH1A1 P00352 8/20 0.39
RXFP1 Q9HBX9 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 3/20 0.37
RECQL P46063 2/20 0.37
RCE1 Q9Y256 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
POLB P06746 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235373 0.91 HSD17B10 (0.74) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6686477 0.89 CYP2C9 (0.63) HSD17B10MAPK1CYP2C9NR1I2L3MBTL1
SCHEMBL6236195 0.88 MAPK1 (0.68) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6693292 0.87 CYP2C9 (0.70) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6681450 0.85 CYP2C9 (0.66) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6242538 0.85 MAPK1 (0.64) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6238653 0.83 CYP2C9 (0.62) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6235524 0.82 MAPK1 (0.67) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6685735 0.82 MAPK1 (0.57) HSD17B10MAPK1CYP2C9NR1I2KDM4E
SCHEMBL6235728 0.81 HSD17B10 (0.68) HSD17B10MAPK1CYP2C9NR1I2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004052312-A2 ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2004-06-24 WO disclosed